Search research articles
Contact Us
Filters
Showing results (571-580 of 759) with videos related to
Page
of 76
Sort By:
JACC. Advances
|
June 18, 2026
Diagnostic Performance of the Mayo ATTR-CM Score in Diverse Populations: Comparison With the AMY Score
Patricia Carey, Nelson I Barrera, Gregorio Tersalvi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma
Martha Q Lacy, Suzanne R Hayman, Morie A Gertz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 29, 2008
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy
Martha Q Lacy, Angela Dispenzieri, Suzanne R Hayman, et al.
Blood Cancer Journal
|
May 15, 2023
Conditional survival in multiple myeloma and impact of prognostic factors over time
Nadine H Abdallah, Alexandra N Smith, Susan Geyer, et al.
Blood Cancer Journal
|
August 7, 2025
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis
Elham Askari, Angela Dispenzieri, Francis K Buadi, et al.
American Journal of Hematology
|
February 10, 2017
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis
Rahma Warsame, Shaji K Kumar, Morie A Gertz, et al.
Blood Advances
|
November 13, 2024
Retreatment of multiple myeloma with previously refractory drugs
Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, et al.
Circulation. Cardiovascular Imaging
|
December 8, 2025
Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour <sup>99m</sup>Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison
Gregorio Tersalvi, Patricia Carey, Armin Garmany, et al.
American Journal of Hematology
|
June 11, 2021
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials
M Hasib Sidiqi, Abdullah S Al Saleh, Shaji K Kumar, et al.
JACC. Cardiooncology
|
November 29, 2022
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
Esther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, et al.
Page
of 76
Search research articles
Search
Showing results (571-580 of 759) with videos related to
Sort By:
Page
of 76
JACC. Advances
|
June 18, 2026
Diagnostic Performance of the Mayo ATTR-CM Score in Diverse Populations: Comparison With the AMY Score
Patricia Carey, Nelson I Barrera, Gregorio Tersalvi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma
Martha Q Lacy, Suzanne R Hayman, Morie A Gertz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 29, 2008
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy
Martha Q Lacy, Angela Dispenzieri, Suzanne R Hayman, et al.
Blood Cancer Journal
|
May 15, 2023
Conditional survival in multiple myeloma and impact of prognostic factors over time
Nadine H Abdallah, Alexandra N Smith, Susan Geyer, et al.
Blood Cancer Journal
|
August 7, 2025
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis
Elham Askari, Angela Dispenzieri, Francis K Buadi, et al.
American Journal of Hematology
|
February 10, 2017
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis
Rahma Warsame, Shaji K Kumar, Morie A Gertz, et al.
Blood Advances
|
November 13, 2024
Retreatment of multiple myeloma with previously refractory drugs
Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, et al.
Circulation. Cardiovascular Imaging
|
December 8, 2025
Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour <sup>99m</sup>Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison
Gregorio Tersalvi, Patricia Carey, Armin Garmany, et al.
American Journal of Hematology
|
June 11, 2021
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials
M Hasib Sidiqi, Abdullah S Al Saleh, Shaji K Kumar, et al.
JACC. Cardiooncology
|
November 29, 2022
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
Esther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, et al.
Page
of 76